IGF2BP2 and cancer: These results suggest that IGF2BP2 loss disrupts OXPHOS and by extension mitochondrial ATP production, preferentially impairing the viability of PLK1-overexpressing cancer cells, which are known to be addicted to higher metabolic activity.77